Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L SHAFFER

Showing results (121-130 of 523) with videos related to

Pageof 53
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2009
Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound dispositionChristopher L Shaffer, Mithat Gunduz, Tim F Ryder, et al.
British Journal of Clinical Pharmacology|April 1, 1985
A comparison of standard and sustained release clonidine with respect to plasma concentration and blood pressure changesJ L Shaffer, B J Pleuvry, D S Davies, et al.
Clinical Case Reports|September 20, 2019
Monozygotic dichorionic diamniotic twins with large interstitial deletion of chromosome 1pLeah Yieh, Christina Ramo, Cori Feist, et al.
American Journal of Obstetrics and Gynecology|September 7, 2016
Gastroschisis: mortality risks with each additional week of expectant managementTeresa N Sparks, Brian L Shaffer, Jessica Page, et al.
International Reviews of Immunology|January 8, 2000
Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6L M Staudt, A L Dent, A L Shaffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
The signaling activity of murine CD19 is regulated during cell developmentI Krop, A L Shaffer, D T Fearon, et al.
Postgraduate Medical Journal|September 1, 1981
Tinnitus in a patient with beta-thalassaemia intermedia on long-term treatment with desferrioxamineM N Marsh, I B Holbrook, C Clark, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 23, 2006
Using a tritiated compound to elucidate its preclinical metabolic and excretory pathways in vivo: exploring tritium exchange riskChristopher L Shaffer, Mithat Gunduz, Bruce A Thornburgh, et al.
The Journal of Cell Biology|June 1, 1979
Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK)M J Rindler, L M Chuman, L Shaffer, et al.
Biopharmaceutics & Drug Disposition|January 4, 2012
Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse eventsChristopher L Shaffer, Renato J Scialis, Haojing Rong, et al.
Pageof 53

Showing results (121-130 of 523) with videos related to

Sort By:
Pageof 53
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2009
Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound dispositionChristopher L Shaffer, Mithat Gunduz, Tim F Ryder, et al.
British Journal of Clinical Pharmacology|April 1, 1985
A comparison of standard and sustained release clonidine with respect to plasma concentration and blood pressure changesJ L Shaffer, B J Pleuvry, D S Davies, et al.
Clinical Case Reports|September 20, 2019
Monozygotic dichorionic diamniotic twins with large interstitial deletion of chromosome 1pLeah Yieh, Christina Ramo, Cori Feist, et al.
American Journal of Obstetrics and Gynecology|September 7, 2016
Gastroschisis: mortality risks with each additional week of expectant managementTeresa N Sparks, Brian L Shaffer, Jessica Page, et al.
International Reviews of Immunology|January 8, 2000
Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6L M Staudt, A L Dent, A L Shaffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
The signaling activity of murine CD19 is regulated during cell developmentI Krop, A L Shaffer, D T Fearon, et al.
Postgraduate Medical Journal|September 1, 1981
Tinnitus in a patient with beta-thalassaemia intermedia on long-term treatment with desferrioxamineM N Marsh, I B Holbrook, C Clark, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 23, 2006
Using a tritiated compound to elucidate its preclinical metabolic and excretory pathways in vivo: exploring tritium exchange riskChristopher L Shaffer, Mithat Gunduz, Bruce A Thornburgh, et al.
The Journal of Cell Biology|June 1, 1979
Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK)M J Rindler, L M Chuman, L Shaffer, et al.
Biopharmaceutics & Drug Disposition|January 4, 2012
Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse eventsChristopher L Shaffer, Renato J Scialis, Haojing Rong, et al.
Pageof 53